Ellen Bradley, MD, is an assistant professor of psychiatry and behavioral sciences at the University of California, San Francisco (UCSF), associate director of the UCSF translational psychedelic research (TrPR) program and lead psychiatrist for the Parkinson’s disease Research, Education, and Clinical Center (PADRECC) at the San Francisco VA Medical Center. Her goal is to advance effective, multidisciplinary care for people living with neuropsychiatric disorders through clinical practice and research. She uses mechanistic clinical trials to understand the effects of psychoactive drugs and their potential as treatments for illnesses that span the psychiatry-neurology divide, including Parkinson’s disease (PD). Dr. Bradley leads the TrPR program’s studies focused on neurodegenerative disorders and she is currently investigating the effects of psilocybin in PD.